"First lesson"

#11950592

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950596

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950599

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950602

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950606

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950610

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950614

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950618

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11933718

10 January 2025

The Jourhaus and entrance of the Dachau Concentration Camp in Germany are depicted in this photograph. Dachau is one of the first Nazi camps established during World War II. This image serves as a reminder of the atrocities of the Holocaust and the importance of preserving historical memory for future generations in Dachau, Germany, on March 3, 2023.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11933772

10 January 2025

The Jourhaus and entrance of the Dachau Concentration Camp in Germany are depicted in this photograph. Dachau is one of the first Nazi camps established during World War II. This image serves as a reminder of the atrocities of the Holocaust and the importance of preserving historical memory for future generations in Dachau, Germany, on March 3, 2023.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11272108

25 May 2024

Prime Minister Gabriel Attal and First Lady Brigitte Macron are attending a class with the children of a primary school during an anti-bullying lesson in Antony, France, on May 24, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11272093

25 May 2024

PM Gabriel Attal and Brigitte Macron are with the headmistress and primary school children during an anti-bullying lesson in Antony, France, on May 24, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11269524

24 May 2024

First Lady Brigitte Macron is returning to the classroom with children from a primary school during an anti-bullying lesson in Antony, France, on May 24, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11269526

24 May 2024

First Lady Brigitte Macron is returning to the classroom with children from a primary school during an anti-bullying lesson in Antony, France, on May 24, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11269529

24 May 2024

Prime Minister Gabriel Attal is sharing a hug with First Lady Brigitte Macron during an anti-bullying lesson at a primary school south of Paris. One of the central themes is the ability to empathize and the practice of expressing one's emotions. In Antony, France, on May 24, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11269532

24 May 2024

Prime Minister Gabriel Attal and First Lady Brigitte Macron are attending a class with the children of a primary school during an anti-bullying lesson in Antony, France, on May 24, 2024.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.